Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello, everyone, and thank you for holding, and welcome to the ...

The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

The court held that those patents did not satisfy the requirements for listing in the Orange Book, finding that the patents did not claim the drug or drug product for which the associated New Drug ...

The drug and device industries have a lot hinging on the results of the Nov. 5 U.S. presidential and congressional elections.

Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...

Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that ...

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

Ozempic has been considered a wonder drug for managing blood sugar in people with type ... bariatric surgeon and medical ...

Pope Francis was raised in the city’s middle-class Flores neighborhood from the mid-1930s through the ’50s, a time period ...

Trump has not been vocal about healthcare policies but indicated that RFK Jr will have a big influence on the sector.